echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > WuXi Biologics' stock solution production base completed the GMP audit of the Korean Ministry of Food and Drug Safety

    WuXi Biologics' stock solution production base completed the GMP audit of the Korean Ministry of Food and Drug Safety

    • Last Update: 2022-02-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    <>


    The GMP inspection mainly focused on an innovative biological drug that WuXi Biologics provides commercial production services for its global partners.


    Dr.


    About WuXi Biologics

    WuXi Biologics (stock code: 2269.


    As of December 31, 2021, there were 480 comprehensive projects developed on the WuXi Biologics platform, including 268 in preclinical research, 171 in early clinical (Phase I/II), and 32 in late clinical (Phase I/II) Phase III) and 9 in the commercial production stage


    WuXi Biologics regards Environmental, Social and Governance (ESG) as an important part of business development and entrepreneurship, and is committed to becoming a global ESG leader in biopharmaceuticals


    For more information, please contact

    Media Relations


    Investor Relations


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.